The InterSePT suicide scale for prediction of imminent suicidal behaviors

Psychiatry Research

Volumn 161, Issue 1, 2008, Pages 87-96

  Ayer, David W ^a,b,c   Jayathilake, Karu ^c   Meltzer, Herbert Y ^c  

^a Research Department at Centerstone   (United States)

^b WESTERN MICHIGAN UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Calgary Depression Scale (CDS); International Suicide Prevention Trial (InterSePT); InterSePT Scale for Suicidal Thinking (ISST); Schizoaffective disorder; Schizophrenia; Suicide risk

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CLOZAPINE; MOOD STABILIZER; OLANZAPINE;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOMETRY; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; PERSONALITY INVENTORY; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOTIC DISORDERS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SINGLE-BLIND METHOD; SUICIDE; SUICIDE, ATTEMPTED; THINKING;

EID: 52149109923     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2007.07.029     Document Type: Article

References (41)

1. Addington D., Addington J., and Schissel B. A depression rating scale for schizophrenics. Schizophrenia Research 3 (1990) 247-251
2. Addington D., Addington J., Maticka-Tyndale E., and Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophrenia Research 6 (1992) 201-208
3. Addington D., Addington J., and Maticka-Tyndale E. Specificity of the Calgary Depression Scale for schizophrenia. Schizophrenia Research 11 (1994) 239-244
4. Addington D., Addington J., and Atkinson M. A psychometric comparison of the Calgary Depression Scale for schizophrenia and the Hamilton Depression Rating Scale. Schizophrenia Research 19 (1996) 205-212
5. Alphs L., Anand R., Islam M.Z., Meltzer H.Y., Kane J.M., Krishnan R., Green A.I., Potkin S., Chouinard G., Lindenmayer J.P., and Kerwin R. The international suicide prevention trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients. Schizophrenia Bulletin 30 (2004) 577-586
6. Axelsson R., and Lagerkvist-Briggs M. Factors predicting suicide in psychotic patients. European Archives of Psychiatry and Clinical Neuroscience 241 (1992) 259-266
7. Beck A.T., Weissman A., Lester D., and Trexler L. The measurement of pessimism: The Hopelessness Scale. Journal of Consulting and Clinical Psychology 42 (1974) 861-865
8. Beck A.T., Kovacs M., and Weissman A. Assessment of suicidal intention: the scale for suicide ideation. Journal of Consulting and Clinical Psychology 47 (1979) 343-352
9. Boardman A.P., Grimbaldeston A.H., Handley C., Jones P.W., and Willmott S. The North Staffordshire Suicide Study: a case-control study of suicide in one health district. Psychological Medicine 29 (1999) 27-33
10. Bostwick J.M., and Pankratz V.S. Affective disorders and suicide risk: a reexamination. American Journal of Psychiatry 157 (2000) 1925-1932
11. Caldwell C.B., and Gottesman I.I. Schizophrenia: a high-risk factor for suicide: clues to risk reduction. Suicide and Life-Threatening Behavior 22 (1992) 479-493
12. Cochrane-Brink K.A., Lofchy J.S., and Safinosky I. Clinical rating scales in suicide risk assessment. General Hospital Psychiatry 22 (2000) 445-451
13. Cohen L.J., Test M.A., and Brown R.L. Suicide and schizophrenia: data from a prospective community treatment. American Journal of Psychiatry 17 (1990) 602-607
14. Collins A.A., Remington G., Coulter K., and Birkett K. Depression in schizophrenia: a comparison of three measures. Schizophrenia Research 20 (1996) 205-209
15. Drake R.E., Gates C., Whitaker A., and Cotton P.G. Suicide among schizophrenics: a review. Comparative Psychiatry 26 (1985) 90-100
16. Goldner E.M., Hsu L., Waraich P., and Somers J.M. Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature. Canadian Journal of Psychiatry 47 (2002) 833-843
17. Harriss L., and Hawton K. Suicidal intent in deliberate self-harm and the risk of suicide: the predictive power of the suicide intent scale. Journal of Affective Disorders 86 (2005) 225-233
18. Heila H., Isometsa E.T., Henriksson M.M., Heikkinen M.E., Marttunen M.J., and Lonnqvist J.K. Suicide and schizophrenia: a nationwide psychological autopsy study on age-and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. American Journal of Psychiatry 154 (1997) 1235-1242
19. Hennen J., and Baldessarini R.J. Suicidal risk during treatment with clozapine: a meta-analysis. Schizophrenia Research 73 2-3 (2005) 139-145
20. Kim C.-H., Jayathilake K., and Meltzer H.Y. Hopelessness, neurocognitive function, and insight in schizophrenia: relationship to suicidal behavior. Schizophrenia Research 60 (2003) 71-80
21. Kontaxakis V.P., Havaki-Kontaxaki B.J., Stamouli S.S., Margariti M.M., Collias C.T., and Christodoulou G.N. Comparison of four scales measuring depression in schizophrenic inpatients. European Psychiatry 15 (2000) 274-277
22. Lancon C., Auquier P., Reine G., Bernard D., and Toumi M. Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS). Journal of Affective Disorders 58 (2000) 107-115
23. Lindenmayer J.P., Czobor P., Alphs L., Nathan A.-M., Anand R., Islam Z., and Chou J.C.Y. The InterSePT scale for suicidal thinking reliability and validity. Schizophrenia Research 63 (2003) 161-170
24. Meltzer H.Y. Suicidality in schizophrenia: a review of the evidence for risk factors and treatment options. Current Psychiatry Reports 4 4 (2002) 279-283
25. Meltzer H.Y. Suicide in schizophrenia, clozapine, and adoption of evidence-based medicine. Journal of Clinical Psychiatry 66 4 (2005) 530-533
26. Meltzer H.Y., and Fatemi H. Suicide in schizophrenia: the effect of clozapine. Clinical Neuropharmacology 18 (1995) S18-S24 (suppl)
27. Meltzer H.Y., and Okayli G. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. American Journal of Psychiatry 152 (1995) 183-190
28. Meltzer H.Y., Alphs L., Green A.I., Altamura A.C., Anand R., Bertoldi A., Bourgeois M., Chouinard G., Islam M.Z., Kane J., Krishman R., Lindenmayer J.P., and Potkin S. Clozapine treatment for suicidality in schizophrenia. Archive of General Psychiatry 60 (2003) 82-91
29. Muller J.M., Brening H., Gensch C., Klinga J., Kienzle B., and Muller K.M. The Calgary depression rating scale for schizophrenia in a healthy control group: psychometric properties and reference values. Journal of Affective Disorders 88 (2005) 69-74
30. Muzina D.J. What physicians can do to prevent suicide. Cleveland Clinic Journal of Medicine 71 3 (2004) 242-250
31. Nimeus A., Alsen M., and Traskman-Bendz L. High suicidal intent scores indicate future suicide. Archives of Suicide Research 6 (2002) 211-219
32. Nyman A., and Jonsson H. Patterns of self-destructive behaviour in schizophrenia. Acta Psychiatrica Scandinavica 73 (1986) 252-262
33. Palmer B.A., Pankratz S., and Bostwick J.M. The lifetime risk of suicide in schizophrenia. Archives of General Psychiatry 62 (2005) 247-253
34. Pinninti N., Steer R.A., Rissmiller D.J., Nelson S., and Beck A.T. Use of the Beck scale for suicide ideation with psychiatric inpatients diagnosed with schizophrenia, schizoaffective, or bipolar disorders. Behavior Research and Therapy 40 (2002) 1071-1079
35. Powell J., Geddes J., Deeks J., Goldacre M., and Hawton K. Suicide in psychiatric hospital in-patients. British Journal of Psychiatry 176 (2000) 266-272
36. Potkin S.G., Alphs L., Hsu C., Krishnan K.R.R., Anand R., Young F.K., Meltzer H., and Green A. Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial. Biological Psychiatry 54 (2003) 444-452
37. Preston E., and Hansen L. A systematic review of suicide rating scales in schizophrenia. Crisis 26 4 (2005) 170-180
38. Sakinofsky I., Heila H., and Krishnan R. Estimating suicidality as an outcome measure in clinical trials of suicide in schizophrenia. Schizophrenia Bulletin 30 3 (2004) 587-598
39. Suominen K., Isometa E., Ostamo A., and Lonnqvist J. Level of suicidal intent predicts overall mortality after attempted suicide: a 12-year follow-up study. BMC Psychiatry 4 (2004) 11
40. Taiminen T., Huttunen J., Heila H., Henriksson M., Isometsa E., Kahkonen J., Touminen, Lonnqvist J., Addington D., and Helenius H. The schizophrenia suicide risk scale (SSRS): development and initial validation. Schizophrenia Research 47 (2001) 199-213
41. Weiser M., Davidson M., and Noy S. Comments on risk for schizophrenia. Schizophrenia Research 79 (2005) 15-21